UC Davis Environmental Health Sciences Core Center
Project Number3P30ES023513-07S1
Former Number5P30ES023513-07
Contact PI/Project LeaderHERTZ-PICCIOTTO, IRVA
Awardee OrganizationUNIVERSITY OF CALIFORNIA AT DAVIS
Description
Abstract Text
ABSTRACT
Latinos have disproportionately suffered from COVID-19. In California, Latinos make up 39% of the population
but 46% of deaths and more than half of all cases. Agricultural employees are essential workers and the risk of
SARS-CoV-2 transmission is high because social distancing and masking are difficult—especially in very hot
weather. In addition, the risk of SARS-CoV-2 transmission within households is high as one-third of agricultural
employees live in crowded and multi-family housing (>1 persons/room). In these households, self-isolation or
quarantine is simply not feasible when a family member has been exposed. Non-pharmaceutical interventions
such as testing, social distancing, quarantine, and isolation have played a critical role in mitigating the impact of
COVID-19. However, despite being at increased risk of infection, testing rates among Latinos is lower compared
to Whites and Latinos are more likely to be positive when tested and to require higher level of care at the time of
positive test. In the US, nearly 13% of Hispanic or Latino have received at least one dose, and 10% have been
fully vaccinated, despite eligibility open to all on April 19th, 2021.There is a major gap in COVID-19 vaccination
among underserved and/or vulnerable Latino population. We propose a three-tiered approach to address
barriers to COVID-19 vaccination in predominantly Latino counties in California, Yolo, Fresno, Madera, and
Stanislaus. ÓRALE COVID-19! was proposed to overcome motivational and logistic barriers to testing by
decreasing the time from symptoms, to seeking testing, to securing testing, to receiving test results, to consult
about self-isolation, quarantine, and increase the proportion who successfully self-isolated and quarantine. The
aims of this study are to: (1) reduce vaccine hesitancy, improve vaccine update while continuing to promote
testing with culturally and linguistically appropriate targeted communication and incentives guided by trusted
community partners, (2) Develop a literacy-supported decision making process to reduce vaccine hesitancy,
improve vaccine update while continuing to promote testing, and (3) evaluate the impact of interventions on
vaccine hesitancy, uptake of vaccine and testing through robust statistical and mathematical models that provide
a flexible framework to evaluate different scenarios of vaccine rollout. The proposed study will leverage strong
community partnerships, expertise of collaborators with local CEAL member to incorporate CEAL-developed
resources that will strengthen the implementation of our interventions, strong team organization, survey
development expertise, translation of materials that will be critical for communication and dissemination, robust
data capturing, harmonization, statistical, and modeling support, evaluation unit, and testing data that can be
integrated to vaccination efforts to allow for a comprehensive characterization and evaluation of interventions on
vaccine hesitancy and uptake. Vaccine prioritization and access to regular testing to Latino farmer worker
communities that experience structural barriers such as overcrowded housing and have strong cultural values
on support of large extended facilities is critical to reduce the burden associated with COVID-19.
Public Health Relevance Statement
PROPOSAL NARRATIVE
Latino essential workers bear the brunt of the COVID-19 pandemic. In California, Latinos make up 40% of the
population but 48% of deaths and 63% of all cases. Despite high vaccine rollout in the US, with 45% of its
population administered at least one dose, 13% of Latino have been vaccinated. We propose an evidence-
informed three-tiered approach to improve vaccine uptake in Latino communities of the Central Valley of
California, a population disproportionately impacted by the COVID-19 pandemic.
National Institute of Environmental Health Sciences
CFDA Code
113
DUNS Number
047120084
UEI
TX2DAGQPENZ5
Project Start Date
05-May-2015
Project End Date
31-March-2025
Budget Start Date
17-September-2021
Budget End Date
31-March-2024
Project Funding Information for 2021
Total Funding
$278,846
Direct Costs
$177,609
Indirect Costs
$101,237
Year
Funding IC
FY Total Cost by IC
2021
NIH Office of the Director
$278,846
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3P30ES023513-07S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3P30ES023513-07S1
Patents
No Patents information available for 3P30ES023513-07S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3P30ES023513-07S1
Clinical Studies
No Clinical Studies information available for 3P30ES023513-07S1
News and More
Related News Releases
No news release information available for 3P30ES023513-07S1
History
No Historical information available for 3P30ES023513-07S1
Similar Projects
No Similar Projects information available for 3P30ES023513-07S1